D. Western Therapeutics Institute, Inc. (TYO:4576)
104.00
0.00 (0.00%)
Oct 29, 2025, 2:29 PM JST
TYO:4576 Revenue
D. Western Therapeutics Institute had revenue of 76.24M JPY in the quarter ending June 30, 2025, a decrease of -35.93%. This brings the company's revenue in the last twelve months to 421.00M, down -9.27% year-over-year. In the year 2024, D. Western Therapeutics Institute had annual revenue of 471.00M with 10.05% growth.
Revenue (ttm)
421.00M
Revenue Growth
-9.27%
P/S Ratio
11.30
Revenue / Employee
20.05M
Employees
21
Market Cap
4.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 471.00M | 43.00M | 10.05% |
| Dec 31, 2023 | 428.00M | -20.00M | -4.46% |
| Dec 31, 2022 | 448.00M | 34.00M | 8.21% |
| Dec 31, 2021 | 414.00M | 59.00M | 16.62% |
| Dec 31, 2020 | 355.00M | -225.00M | -38.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |